Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Stem Cell-Based Therapies for Multiple Sclerosis: Current Perspectives.

Cuascut FX, Hutton GJ.

Biomedicines. 2019 Mar 30;7(2). pii: E26. doi: 10.3390/biomedicines7020026. Review.

2.

Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury.

Busch SA, Hamilton JA, Horn KP, Cuascut FX, Cutrone R, Lehman N, Deans RJ, Ting AE, Mays RW, Silver J.

J Neurosci. 2011 Jan 19;31(3):944-53. doi: 10.1523/JNEUROSCI.3566-10.2011.

3.

Adult NG2+ cells are permissive to neurite outgrowth and stabilize sensory axons during macrophage-induced axonal dieback after spinal cord injury.

Busch SA, Horn KP, Cuascut FX, Hawthorne AL, Bai L, Miller RH, Silver J.

J Neurosci. 2010 Jan 6;30(1):255-65. doi: 10.1523/JNEUROSCI.3705-09.2010.

4.

PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration.

Shen Y, Tenney AP, Busch SA, Horn KP, Cuascut FX, Liu K, He Z, Silver J, Flanagan JG.

Science. 2009 Oct 23;326(5952):592-6. doi: 10.1126/science.1178310. Epub 2009 Oct 15.

5.

Supplemental Content

Loading ...
Support Center